Navigation Links
PDL BioPharma to Present at Two Upcoming Investor Conferences
Date:2/20/2013

INCLINE VILLAGE, Nev., Feb. 20, 2013  /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin , the company's president and chief executive officer, will present at the following upcoming conferences.

RBC Capital Markets Healthcare Conference
Wednesday, February 27, 2013
9:00 a.m. ET
New York City

Cowen and Company 33rd Annual Healthcare Conference
Wednesday, March 6, 2013
9:20 a.m. ET
Boston, MA

(Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)

To access the live and subsequently archived webcasts of the presentations, go to the Company's website at http://www.pdl.com and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary. The archived webcast will be available for seven days following each presentation.

About PDL BioPharma

PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new revenue generating assets and maximizing value for its shareholders. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.


'/>"/>
SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
2. Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET
3. Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2013
4. Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer
5. Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2013 On February 4, 2013
6. Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting
7. TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
8. Array BioPharma Announces Exercise And Closing Of Underwriters Over-Allotment Option
9. Gallus BioPharmaceuticals Announces Appointment of Senior Baxter Executive as Chief Commercial Officer
10. PDL BioPharma to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
11. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... MA and Azusa, CA (PRWEB) , ... December ... ... provider of distributed wastewater treatment and resource recovery solutions for industrial facilities, today ... Company , will be the first to use Cambrian’s novel water-energy purchase agreement ...
(Date:12/6/2016)... The American Botanical Council (ABC) recognizes ... ( Arnica montana ) through ABC,s Adopt-an-Herb program. ... database, a comprehensive, interactive online tool that ... data on the uses and health effects of ... a wellness company with healing arts centers, skin ...
(Date:12/6/2016)... and Albany, NY (PRWEB) , ... December 06, ... ... control system integrator of custom industrial automation and IT solutions, today announced the ... Superior Controls has reliably delivered professionally executed automation and control systems integration services ...
(Date:12/6/2016)... 2016 Zimmer Biomet Holdings, Inc. (NYSE ... pricing terms of its previously-announced cash tender offers ... price (excluding accrued and unpaid interest to, but ... fees and expenses related to the Offers) (the ... in the table below (collectively, the "Notes"). The ...
Breaking Biology Technology:
(Date:12/6/2016)... -- Valencell , the leading innovator in performance ... third consecutive year of triple digit growth for its ... a 360 percent increase in companies who have acquired ... by sales of its wrist and ear Benchmark™ sensor ... for hearables for fitness and healthcare applications. ...
(Date:12/2/2016)... PUNE, India , December 1, 2016 /PRNewswire/ ... Market by Authentication type (Fingerprint, Voice), Future Technology (Iris ... Vehicle), and Region - Global Forecast to 2021", ... be USD 442.7 Million in 2016, and is ... 2021, at a CAGR of 14.06%. ...
(Date:11/30/2016)... CHICAGO , Nov. 30, 2016  higi ... a new partnership initiative targeting national brands, industry ... and reward their respective audiences for taking steps ... Since its inception in 2012, higi has built ... US, impacting over 38 million people who have ...
Breaking Biology News(10 mins):